[1]
Sun, B. et al. 2026. MiR-519d-3p REDUCES OSTEOCLASTOGENESIS BY LOWERING MMP2 AND SHIFTING OSTEOBLAST SIGNALING TOWARD OSTEOPROTEGERIN. Experimental Oncology. 47, 4 (Mar. 2026), 492–497. DOI:https://doi.org/10.15407/exp-oncology.2025.04.492.